Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
V-Co Investors 3 LLC is a private investment vehicle and an affiliate of New Seneca Partners, a Michigan-based private equity firm. The company operates as a strategic institutional investor within the healthcare and medical technology sectors, notably maintaining a significant ownership stake in Vivos Therapeutics, Inc. (NASDAQ: VVOS). Managed by SP Manager LLC, V-Co Investors 3 provides capital through structured equity financing, private placements, and convertible debt to support the growth of companies developing innovative medical devices and therapeutic solutions for sleep-disordered breathing. The entity is led by Managing Director Michael C. Skaff and plays an active role in the financial and strategic oversight of its portfolio investments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on V-Co Investors 3.